Loading...
Pazopanib in the management of advanced soft tissue sarcomas
Therapy of soft tissue sarcomas represents an area of significant unmet need in oncology. Angiogenesis has been explored as a potential target both preclinically and clinically, with suggestions of activity. Pazopanib is a multitargeted tyrosine kinase inhibitor with prominent antiangiogenic effects...
Na minha lista:
| Udgivet i: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907704/ https://ncbi.nlm.nih.gov/pubmed/27354810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S84792 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|